产品介绍
Product Description
The QIAseq SARS-CoV-2 Primer Panel is specially designed to advance research into SARS-CoV-2, which is the causative agent of COVID-19 disease. This kit, when paired with a QIAseq FX DNA Library UDI Kit, is a solution for enriching and sequencing the entire viral genome. SARS-CoV-2 is encoded by a positive-sense, single-stranded RNA molecule that can be mixed with host RNA during isolation from a sample. The kit includes reagents to reverse transcribe the RNA into cDNA and primers to specifically enrich for its genome. The panel consists of over 200 primer pairs, covering the full 29.9 kb viral genome. Want to try the QIAseq SARS-CoV-2 Primer Panel for the first time? Request a quote for a trial kit. Want to try the QIAseq FX DNA Library UDI Kit for the first time? Request a quote for a trial kit.
产品特点
Features
- High-fidelity reagents for reverse transcription and enrichment of SARS-CoV-2 RNA
- When paired with a QIAseq FX DNA Library Unique Dual Index (UDI) Kit, multiplex 384 samples in a single run
- Fast 3–3.5 hour enrichment workflow with limited hands-on time
- Powerful tool for genomic surveillance efforts for detection of new SARS-CoV-2 variants
- High-throughput NGS for rapid scale-up of lab capabilities
产品应用
Applications
The QIAseq SARS-CoV-2 Primer Panel can be used to generate whole genome coverage of the SARS-CoV-2 viral genome for epidemiological research purposes.
With the ability to multiplex up to 384 samples, the panel allows labs to rapidly scale up sequencing capabilities and ramp up SARS-CoV-2 genomic surveillance efforts. Accurate amplification and high SARS-CoV-2 genome coverage enables the detection of new variants with unparalleled precision.
